Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study.
Carlos King-Ho WongMarshall C H LowAshley C Y KwokAngel Y C LuiKristy Tsz Kwan LauIvan Chi Ho AuXi XiongMatthew Shing Hin ChungMike Yat-Wah KwanEric Ho Yin LauBenjamin John CowlingPublished in: Paediatric drugs (2022)
Early treatment with LPV/r for pediatric COVID-19 patients was associated with longer time to clinical improvement. Our study advocates the recommendation against LPV/r use for pediatric patients across age groups.